Published in Blood on July 01, 1987
Interleukin 4 inhibits in vitro proliferation of leukemic and normal human B cell precursors. J Clin Invest (1992) 0.80
Response of neoplasms of B cell lineage to the proliferative effects of B cell growth factor and the phorbol ester TPA. Am J Pathol (1989) 0.75
Negative modulation of Epstein-Barr virus episomes by a human B-cell growth factor. J Virol (1989) 0.75
Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med (2001) 20.20
Immunoglobulin gene rearrangement and cell surface antigen expression in acute lymphocytic leukemias of T cell and B cell precursor origins. J Clin Invest (1983) 2.91
The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology (ESMO). Ann Oncol (2013) 2.53
A monoclonal antibody (BA-1) reactive with cells of human B lymphocyte lineage. J Immunol (1981) 2.52
Paraneoplastic hypokalemia in acute myeloid leukemia: a case of renin activity in AML blast cells. Ann Hematol (1996) 2.05
Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML. Leukemia (2000) 1.91
P-24: a human leukemia-associated and lymphohemopoietic progenitor cell surface structure identified with monoclonal antibody. J Exp Med (1981) 1.79
The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease. Eur Heart J (2000) 1.72
Combination chemotherapy with CHOP for recurrent thrombotic thrombocytopenic purpura. Br J Haematol (1997) 1.71
Human T lymphocyte/monocyte interaction in response to lectin: kinetics of entry into the S-phase. J Immunol (1981) 1.62
Purification of human B cell growth factor. J Immunol (1985) 1.61
Interstitial mononuclear cell populations in renal graft rejection. Identification by monoclonal antibodies in tissue sections. J Exp Med (1982) 1.59
A monoclonal antibody to sialophorin (CD43) induces homotypic adhesion and activation of human monocytes. J Exp Med (1989) 1.51
Safety outcomes in meta-analyses of phase 2 vs phase 3 randomized trials: Intracranial hemorrhage in trials of bolus thrombolytic therapy. JAMA (2001) 1.50
Effect of interleukin 1 on human thymocytes and purified human T cells. J Exp Med (1981) 1.50
Stages of renal ontogenesis identified by monoclonal antibodies reactive with lymphohemopoietic differentiation antigens. J Exp Med (1983) 1.48
The human B cell-associated antigen CD24 is a single chain sialoglycoprotein. J Immunol (1986) 1.43
Congenital afibrinogenaemia. J Assoc Physicians India (1989) 1.39
Autologous bone marrow transplantation in non-Hodgkin's lymphoma: monoclonal antibodies plus complement for ex vivo marrow treatment. Am J Med (1988) 1.39
mRNA in human cells contains sequences complementary to the Alu family of repeated DNA. Proc Natl Acad Sci U S A (1981) 1.32
Management of acute myeloid leukemia in elderly patients. J Clin Oncol (1999) 1.25
Soluble factor activation of human B lymphocytes. Nature (1981) 1.22
Long-term growth of human B cells and their use in a microassay for B-cell growth factor. Proc Natl Acad Sci U S A (1983) 1.20
In vivo collagen turnover following experimental balloon angioplasty injury and the role of matrix metalloproteinases. Circ Res (1996) 1.19
Incidental findings in healthy control research subjects using whole-body MRI. Eur J Radiol (2008) 1.14
Comparative analysis of NFAT (nuclear factor of activated T cells) complex in human T and B lymphocytes. J Biol Chem (1993) 1.13
A monoclonal antibody (TA-1) reactive with human T lymphocytes and monocytes. J Immunol (1980) 1.09
S-HAM induction chemotherapy with or without GM-CSF in patients with high-risk myelodysplastic syndromes. Ann Hematol (1997) 1.09
Induction of the IL-13 receptor alpha2-chain by IL-4 and IL-13 in human keratinocytes: involvement of STAT6, ERK and p38 MAPK pathways. Oncogene (2001) 1.07
High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCG. Leukemia (2009) 1.07
Plasmacytosis in acute myeloid leukemia: two cases of plasmacytosis and increased IL-6 production in the AML blast cells. Ann Hematol (1998) 1.07
Introduction of an activated N-ras oncogene alters the growth characteristics of the interleukin 6-dependent myeloma cell line ANBL6. Cancer Res (1995) 1.04
Falciparum malaria--present day problems. An experience with 425 cases. J Assoc Physicians India (1989) 1.02
Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia. N Engl J Med (1987) 1.01
Trastuzumab and breast cancer. N Engl J Med (2001) 1.01
Signaling through CD19 activates Vav/mitogen-activated protein kinase pathway and induces formation of a CD19/Vav/phosphatidylinositol 3-kinase complex in human B cell precursors. J Biol Chem (1994) 1.01
Bcl-xL rescues WEHI 231 B lymphocytes from oxidant-mediated death following diverse apoptotic stimuli. J Immunol (1995) 1.01
Interleukin 7 independent development of human B cells. Proc Natl Acad Sci U S A (1996) 1.01
Structure/function studies of the common acute lymphoblastic leukemia antigen (CALLA/CD10) expressed on human neutrophils. J Immunol (1986) 1.01
dic(9;20): a new recurrent chromosome abnormality in adult acute lymphoblastic leukemia. Genes Chromosomes Cancer (1995) 1.00
Evidence for malignant transformation in acute myeloid leukemia at the level of early hematopoietic stem cells by cytogenetic analysis of CD34+ subpopulations. Blood (1995) 0.99
Differential pattern of DNA-aneuploidy in human malignancies. Pathol Res Pract (1985) 0.99
Anti-T-cell reagents for human bone marrow transplantation: ricin linked to three monoclonal antibodies. Science (1983) 0.99
The growth response to IL-7 during normal human B cell ontogeny is restricted to B-lineage cells expressing CD34. J Immunol (1995) 0.99
Cloning and characterization of two promoters for the human HSAL2 gene and their transcriptional repression by the Wilms tumor suppressor gene product. J Biol Chem (2001) 0.98
Evidence for monomeric and dimeric forms of CD45 associated with a 30-kDa phosphorylated protein. J Biol Chem (1992) 0.98
The phenotype of the neoplastic cells of hairy cell leukemia studied with monoclonal antibodies. Blood (1982) 0.97
Phorbol ester-induced differentiation of a non-T, non-B leukemic cell line: model for human lymphoid progenitor cell development. J Immunol (1982) 0.97
Multiparameter flow cytometric analysis of human fetal bone marrow B cells. Leukemia (1990) 0.97
Human immunoregulatory molecules: interleukin 1, interleukin 2, and B-cell growth factor. Contemp Top Mol Immunol (1983) 0.96
Antibacterial properties of a peroxidogenic strain of Streptococcus mitior (mitis). Can J Microbiol (1975) 0.96
Establishment and characterization of human B-cell lymphoma cell lines using B-cell growth factor. Blood (1990) 0.96
Activating mutations in the N- and K-ras oncogenes differentially affect the growth properties of the IL-6-dependent myeloma cell line ANBL6. Cancer Res (1997) 0.96
Partial tandem duplications of the MLL gene are detectable in peripheral blood and bone marrow of nearly all healthy donors. Blood (1998) 0.96
T-lymphocyte/monocyte interaction in response to phytohemagglutinin. Cell Immunol (1979) 0.95
Heat stroke. J Assoc Physicians India (1987) 0.95
Biased VH gene usage in early lineage human B cells: evidence for preferential Ig gene rearrangement in the absence of selection. J Immunol (1999) 0.95
Development of a bone marrow culture for maintenance and growth of normal human B cell precursors. J Immunol (1991) 0.95
Falciparum malaria--210 cases. J Assoc Physicians India (1986) 0.95
B-cell growth factor receptor expression and B-cell growth factor response of leukemic B cell precursors and B lineage lymphoid progenitor cells. Blood (1987) 0.95
Microenvironmental influences on human B-cell development. Immunol Rev (2000) 0.94
Differentiation of normal human pre-B cells in vitro. J Exp Med (1990) 0.93
Stroke in relation to cardiac procedures in patients with non-ST-elevation acute coronary syndrome: a study involving >18 000 patients. Circulation (2001) 0.93
Control of human lymphocyte proliferation by soluble factors. Lab Invest (1984) 0.92
Preliminary structural characterization of the leukocyte cell surface molecule recognized by monoclonal antibody TA-1. J Immunol (1983) 0.92
SALL1 expression in the human pituitary-adrenal/gonadal axis. J Endocrinol (2002) 0.92
Defective apoptosis due to a point mutation in the death domain of CD95 associated with autoimmune lymphoproliferative syndrome, T-cell lymphoma, and Hodgkin's disease. Exp Hematol (1999) 0.92
Endotoxin concentration in neutropenic patients with suspected gram-negative sepsis: correlation with clinical outcome and determination of anti-endotoxin core antibodies during therapy with polyclonal immunoglobulin M-enriched immunoglobulins. Antimicrob Agents Chemother (1992) 0.92
Establishment of a leukemic cell model for studying human pre-B to B cell differentiation. J Immunol (1989) 0.92
[Diagnosis of and therapy for hepatocellular carcinoma]. Z Gastroenterol (2013) 0.91
Characterization of thymocytes expressing the common acute lymphoblastic leukemia antigen. Leuk Res (1984) 0.90
Construction of an antigenic map for human B-cell precursors. J Clin Immunol (1983) 0.90
Cytogenetic analysis of CD34+ subpopulations in AML and MDS characterized by the expression of CD38 and CD117. Leukemia (1997) 0.89
Unusual patterns of immunoglobulin gene rearrangement and expression during human B cell ontogeny: human B cells can simultaneously express cell surface kappa and lambda light chains. J Exp Med (1993) 0.89
Vitamin D-mediated gene regulation in phenotypically defined human B cell subpopulations. Endocrinology (2000) 0.89
Hsal 1 is related to kidney and gonad development and is expressed in Wilms tumor. Pediatr Nephrol (2001) 0.89
Proliferative effect of interleukin-3 on normal and leukemic human B cell precursors. Leukemia (1989) 0.89
Development of a model for evaluating the interaction between human pre-B acute lymphoblastic leukemic cells and the bone marrow stromal cell microenvironment. Blood (1998) 0.89
Childhood leukemia-lymphoma. Heterogeneity of phenotypes and prognoses. Am J Clin Pathol (1979) 0.89
Growing human B-cell precursors in vitro: the continuing challenge. Immunol Today (1989) 0.88
Pressor effects of alcohol in normotensive and hypertensive subjects. Lancet (1985) 0.88
Growth factors in Hodgkin's disease. Cancer Treat Rep (1982) 0.88
Comparison of the anticoagulant intensities of fondaparinux and enoxaparin in the Organization to Assess Strategies in Acute Ischemic Syndromes (OASIS)-5 trial. J Thromb Haemost (2009) 0.88
Disruption of lymphocyte function and signaling in CD45-associated protein-null mice. J Exp Med (1998) 0.88
A new conditioning regimen involving total marrow irradiation, busulfan and cyclophosphamide followed by autologous PBSCT in patients with advanced multiple myeloma. Bone Marrow Transplant (2003) 0.87
Comparative studies of different stromal cell microenvironments in support of human B-cell development. Exp Hematol (1999) 0.87
Characterization of a xenoantiserum produced against three molar KCl-solubilized antigens obtained from a non-T, non-B (pre-B) acute lymphoblastic leukemia cell line. J Immunol (1979) 0.87
Renin in acute myeloid leukaemia blasts. Br J Haematol (1998) 0.86
Association of herpes virus infection of the esophagus and idiopathic inflammatory bowel disease. Endoscopy (1985) 0.86